Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
Clinical trial NCT05445323 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05445323
- Sponsor
- Lexeo Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2029-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.